Two New FDA-Approved Treatments for RKD

FILSPARI® (sparsentan) has been FDA approved for FSGS, and TRUTAKNA® (atacicept) has been FDA approved for IgAN. More information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Unlock Exclusive Insights: Sign Up and Stay Informed

Love staying informed? Our newsletter brings the latest and greatest straight to your inbox. No spam, just good reads. Sign up and let’s stay in touch!